CUSIP: 33740F326
Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Exchange Traded Product
-
Shares outstanding
-
778,318
-
Total 13F shares
-
501,351
-
Share change
-
+24,183
-
Total reported value
-
$15,238,229
-
Price per share
-
$30.40
-
Number of holders
-
17
-
Value change
-
+$733,055
-
Number of buys
-
8
-
Number of sells
-
11
Quarterly Holders Quick Answers
What is CUSIP 33740F326?
CUSIP 33740F326 identifies XIDE - FIRST TRUST EXCHANGE-TRADED FUND VIII - Exchange Traded Product in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2024
-
Previous quarter:
Q2 2024
Recent filing periods for CUSIP 33740F326:
Institutional Holders of FIRST TRUST EXCHANGE-TRADED FUND VIII - Exchange Traded Product (XIDE) as of Q3 2024
As of 30 Sep 2024,
FIRST TRUST EXCHANGE-TRADED FUND VIII - Exchange Traded Product (XIDE) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
501,351 shares.
The largest 10 holders included
Sequent Planning LLC, Foundations Investment Advisors, LLC, Cetera Investment Advisers, HARBOUR INVESTMENTS, INC., Kestra Advisory Services, LLC, Accel Wealth Management, WORLD EQUITY GROUP, INC., COMMONWEALTH EQUITY SERVICES, LLC, FSB PREMIER WEALTH MANAGEMENT, INC., and Grant Street Asset Management, Inc..
This page lists
17
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.